Review article: The management of acute liver failure

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 5, 1998, Pages 405-418

  Plevris, J N ^a   Schina, M ^a   Hayes, P C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CORTICOSTEROID; CYTOCHROME P450; MANNITOL; PARACETAMOL; PENICILLIN G; SILIBININ; THIOPENTAL; TODRALAZINE;

BRAIN EDEMA; CAUSE OF DEATH; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG OVERDOSE; HUMAN; HYPERVENTILATION; HYPOTENSION; INTRACRANIAL HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; VIRUS HEPATITIS;

ANIMALS; ARTIFICIAL ORGANS; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION;

EID: 0031834353     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00320.x     Document Type: Review

References (120)

1. Trey C, Davidson LS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Disease. New York: Grune & Stratton, 1970: 282-98.
2. Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology 1986; 6: 288-94.
3. Ellis A, Saleh M, Smith H, et al. Late onset hepatic failure: clinical features, serology and outcome following transplantation. J Hepatol 1995; 25: 363-72.
4. Bernuau J, Ruef B, Benhamou J. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986; 6: 97-106.
5. O'Grady JC, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-5.
6. O'Grady J, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
7. Lee W. Acute liver failure. New Engl J Med 1993; 329: 1862-72.
8. Trey C. The fulminant hepatic failure surveillance study: brief review of the effects of presumed aetiology and age on survival. CMAJ 1972; 106: 525-6.
9. Williams R. New directions in acute liver failure. J R Coll Physicians Lond 1994; 28: 552-9.
10. Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: Pathophysiology and management. Semin Liver Dis 1996; 16: 379-88.
11. Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2: 1097-100.
12. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 1572-3.
13. Keays R, Harrison PM, Wendon J, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 1991; 303: 1026-9.
14. Harrison PM, Wendon J, Gimson AE, et al. Improvement by acetylcysteine of haemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-8.
15. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 1448-55.
16. Tibbs C, Williams R. Viral causes and management of acute liver failure. J Hepatol 1995; 22(Suppl. 1): 68-73.
17. Fagan EA, Williams R. Fulminant viral hepatitis. Br Med Bull 1990; 46: 462-80.
18. Hoofnagle J, Carithers R, Jr, Shapiro C, Asher N. Fulminant hepatic failure; Summary of a Workshop. Hepatology 1995; 21: 240-52.
19. Smedile A, Farcy P, Verme G, et al. Influence of delta infection on severity of hepatitis B. Lancet 1982; 2: 945-7.
20. Fagan EA. Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology 1994; 19: 1307-12.
21. Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multi centre study. J Gastroenterol Hepatol 1991; 6: 159-64.
22. Farci P, Alter JH, Shimoda A, et al. Hepatitis C virus associated fulminant hepatic failure. N Engl J Med 1996; 335: 631-4.
23. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347: 92-3.
24. Sallie R, Tibbs C, Silva A, Sheron N, Eddleston A, Williams R. Detection of hepatitis E but not C in the sera of patients with fulminant NANB hepatitis. Hepatology 1991; 14: 68A.
25. Tameda Y, Hamada M, Takase K, Nakano T, Kosaka Y. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative). Hepatology 1996; 23: 465-70.
26. Ellis AJ, Wendon JA, Portmann B, Williams R. Acute liver damage and ecstasy ingestion. Gut 1996; 38: 454-8.
27. Stomer FB, Giannini A, Botti P, et al. Amanita poisoning: a clinical-histopathological study of 64 cases of intoxication. Hepatogastroenterology 1985; 32(5): 229-31.
28. McCullough AJ, Fleming CR, Thistle JL, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 1983; 84: 161-7.
29. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994; 19: 583-7.
30. Hurwitz ES, Barrett MJ, Bregman D, et al. Public health service study of Reye's syndrome and medications. Report of the main study. J Am Med Assoc 1987; 257: 1905-11.
31. Ockner SA, Brunt EM, Conn SM, et al. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology 1990; 11: 59-64.
32. Hughes RD, Wendon J, Gimson AE. Acute liver failure. Gut 1991; 32(Suppl.): 586-91.
33. Bernuau J, Samuel D, Durand R, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: a prospective study. Hepatology 1991; 14: 49A.
34. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-93). Gastroenterology 1995; 109: 1907-16.
35. Crippin JS, Gross JBJ, Lindor KD. Increased intracranial pressure and hepatic encephalopathy in chronic liver disease. Am J Gastroenterol 1992; 87: 879-89.
36. Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral edema in fulminant hepatic failure. J Hepatol 1986; 2: 43-51.
37. Anonymous. The brain in fulminant hepatic failure. Lancet 1991; 338: 156-7.
38. Williams R, Gimson AE. Intensive liver care and management of acute hepatic failure. Dig Dis Sci 1991; 36: 820-6.
39. Keays R, Alexander GJM, Williams R. The safety and the value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol 1993; 18: 205-9.
40. Hanid MA, Davies M, Mellon PJ, et al. Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut 1980; 21: 866-9.
41. Munoz SJ, Robinson M, Northrup B, et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 1990; 13: 209-12.
42. Lidofsky SD, Lake JR, Read AE, et al. Liver transplantation for fulminant hepatic failure: the role of intracranial pressure monitoring. Gastroenterology 1990; 98: A604(Abstract).
43. Lidofsky SD, Bass NM, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992; 16: 1-7.
44. Williams R, Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology 1994; 20: S5-9.
45. Davies M, Mutimer D, Lowes J, Elias E, Neuberger MJ. Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 1994; 343: 1329-30.
46. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341: 157-8.
47. Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral edema of fulminant hepatic failure. Gut 1982; 23: 625-9.
48. Forbes A, Alexander GJM, O'Grady J, et al. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989; 10: 306-10.
49. Wendon J, Harrison PM, Keays R, Williams R. Cerebral blood How and metabolism in fulminant liver failure. Hepatology 1994; 19: 1407-13.
50. Davenport A, Will EJ, Davison AM. Effect of posture on intracranial pressure in patients with fulminant hepatic failure after acetaminophen self-poisoning. Crit Care Med 1990; 18: 286-9.
51. Herrine SK, Northrup B, Bell R, Muñoz SJ. The effect of head elevation on cerebral perfusion pressure in fulminant hepatic failure. Hepatology 1995; 22(4): Pt2 SS 729.
52. Córdoba J, Gottstein J, Blei AT. Mild hypothermia prevents ammonia induced brain edema in rats after portocaval anastomosis. Hepatology 1997; 26(4): Pt2 SS 216.
53. Report from the European Association for the Study of the Liver (EASL). Randomised trial of steroid therapy in acute liver failure. Gut 1979; 20: 620-3.
54. Ware A, Jones RE, Shorey JW, Combes B. A controlled trial of steroid therapy in massive hepatic necrosis. Am J Gastroenterol 1974; 62: 130-3.
55. Rakela J. A double-blinded randomised trial of hydrocortisone in acute hepatic failure study group. Gastroenterology 1979; 76: 1297.
56. Gazzard B, Portmann B, Murray-Lyon IM, Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 1975; 176: 615-25.
57. Rolando N, Harvey F, Braham J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11: 49-53.
58. Salmeron JM, Tito L, Rimola A, et al. Selective intestinal decontamination in patients with acute liver failure. J Hepatol 1992; 14: 280-5.
59. Rolando N, Harvey F, Brahm J. Fungal infection; a common unrecognised complication of acute liver failure. J Hepatol 1991; 12: 1-9.
60. Rolando N, Wade J, Fagan EA, Philpott-Howard J. An open, comparative trial of aztreonam with vancomycin and gent-amicin with piperacillin in patients with fulminant hepatic failure. Antimicrob Agents Chemother 1992; 50: 215-20.
61. Rolando N, Gimson AE, Wade J, et al. Prospective controlled trial of selective parenteral and enterai antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201.
62. Rolando N, Wade J, Stangou A, et al. Prospective study comparing prophylactic parenteral antimicrobials, with or without enterai decontamination, in patients with acute liver failure. Liver Transplant Surg 1996; 2(1): 8-13.
63. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996; 16: 389-402.
64. Harrison PM, O'Grady J, Keays R, Alexander GJM, Williams R. Serial prothrombin time as a prognostic indicator in paracetamol induced fulminant hepatic failure. Br Med J 1990; 301: 964-6.
65. Mackie IJ. The biology of haemostasis and thrombosis. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, 3rd edn. Oxford: Oxford University Press, 1996: 3613-27.
66. O'Grady J, Langley P, Isola LM, et al. Coagulopathy of fulminant liver disease. Semin Liver Dis 1986; 6: 159-63.
67. Pereira SP, Langley P, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996; 16: 403-14.
68. McDougall BR, Williams R. H2 receptor antagonist in the prevention of acute upper gastrointestinal hemorrhage in fulminant hepatic failure: a controlled trial. Gastroenterology 1978; 74: 464-5.
69. McCarthy DM. Sucralfate. New Engl J Med 1991; 325: 1017-25.
70. Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut 1975; 16: 617-20.
71. Goldfarb G, Lebrec D. Percutaneous cannulation of the internal jugular vein in patients with coagulopathies: an experience based on 1,000 attempts. Anesthesiology 1982; 56: 321-3.
72. Makin A, Williams R. The current management of paracetamol overdosage. Br J Clin Pract 1994; 48: 144-8.
73. Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut 1981; 22: 585-91.
74. Wilkinson SP, Blendis IK, Williams R. Frequency and type of renal and electrolyte disorders in fulminant hepatic failure. Br Med J 1974; i: 186-9.
75. Davenport A, Finn R. Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma. Nephron 1988; 50: 55-6.
76. Moore K, Taylor G, Ward P, Williams R. Aetiology and management of renal failure in acute liver failure. In: Williams R, Hughes RD, ed. Acute Liver Failure: Improved Understanding and Better Therapy, Welwyn Garden City, UK: Smith Kline Beecham Pharmaceuticals, 1991: 47-53.
77. Davenport A, Will EJ, Davison AM, et al. Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy. Nephron 1989; 53: 142-6.
78. Davenport A, Will EJ, Davison AM, et al. Changes in intracranial pressure during machine and continuous haemofiltration. Int J Artif Organs 1989; 12: 439-44.
79. Bihari D, Gimson AE, Waterson M, Williams R. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985; 13: 1034-9.
80. Wendon J, Harrison PM, Keays R, Gimson AE, Alexander GJM, Williams R. Effects of vassopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 1992; 15: 1067-71.
81. McCashland TM, Shaw BW, Tape E. The American experience with transplantation for acute liver failure. Semin Liver Dis 1996; 16: 427-33.
82. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Sem Liver Dis 1996; 16: 415-25.
83. Castells A, Salmeron J, Navasa M, Rimola A, Salo J, et al. Liver transplantation for acute liver failure: Analysis of applicability. Gastroenterology 1993; 105: 532-8.
84. Moreno Gonzalez E, Garcia G, Loinaz S, et al. Liver transplantation in patients with fulminant hepatic failure. Br J Surg 1995; 82: 118-21.
85. Bismuth H, Samuel D, Castaing D, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. Ann Surg 1995; 222: 109-19.
86. Asher N, Lake J, Emond J, Roberts J. Liver transplantation for fulminant hepatic failure. Arch Surg 1993; 128: 677-82.
87. Wei Y, Detre K, Everhart J. The NIDDK Liver Transplantation Database. Liver Transplant Surg 1997; 3: 10-22.
88. Pauwels A, Mostefa-Karan N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 1993; 17: 124-7.
89. Anad CA, Nightingale P, Neuberger MJ. Early indicators of prognosis in fulminant hepatic: an assessment of the King's criteria. J Hepatol 1997; 26: 62-8.
90. Van Thiel D. When should a decision to proceed with transplantation actually be made in cases of fulminant or subfulminant hepatic failure: at admission to hospital or when a donor organ is made available? J Hepatol 1993; 17: 1-2.
91. Hockerstedt K, Isionemi H, Ericzon BG, et al. Is a 3-day waiting list appropriate for patients with acute liver failure? Transplant Proc 1994; 26: 1786-7.
92. Bounjema K, Cherqui D, Jaeck D, et al. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure. Transplantation 1995; 59: 218-23.
93. Metselaar HJ, Hesselink EJ, De Rave S, et al. Recovery of failing liver after auxiliary heterotopic transplantation. Lancet 1990; 335: 1156-7.
94. Chenard-Neu MP, Boudjema K, Bernuau J, et al. Auxilliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure. A multicenter European study. Hepatology 1996; 23: 1119-27.
95. Harland RC, Bollinger RR. Extracorporeal hepatic perfusion in the treatment of patients with acute hepatic failure. Transplant Rev 1994; 8: 73.
96. Wang X, Andersson R. Hepatocyte transplantation: A potential treatment for acute liver failure. Scand J Gastroenterol 1995; 30: 193-200.
97. Ringe B, Lubbe N, Kuse E, et al. Management of emergencies before and after liver transplantation by early total hepatectomy. Transplant Proc 1993; 25: 1090.
98. Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayr R. Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg 1993; 218: 3-9.
99. Ejlersen E, Larsen FS, Pott F, et al. Hepatectomy corrects cerebral hyperperfusion in fulminant hepatic failure. Transplant Proc 1994; 26: 1794-5.
100. Rozgo J, Podesta L, LePage E, et al. Total hepatectomy for acute liver failure: don't take out my liver! Gastroenterology 1994; 107: 894-7.
101. Makowka L, Cramer D, Hoffman A, et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995; 59: 1654-9.
102. Cramer D, Sher L, Makowka L. Liver xenotransplantation: Clinical experience and future considerations. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation: The Transplantation of Organs and Tissues between Species. Berlin: Springer, 1991: 559.
103. O'Grady J, Gimson AE, O'Brein CJ, et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-92.
104. Bihari D, Hughes RD, Gimson AE, et al. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int J Artif Organs 1983; 6: 299-302.
105. Gazzard BG, Weston MJ, Murray-Lyon IM, et al. Charcoal hemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974; i: 1301-7.
106. Sorrentino F. Prime ricercheper la realizzatione di un fegato artificiale. Chir Patol Sper 1956; 4: 1401-14.
107. Rozga J, Podesta L, LePage E, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994; 219: 538-46.
108. Dixit V. Development of a bioartificial liver using isolated hepatocytes. Artif Organs 1994; 18: 371-84.
109. Kamlot A, Rozga J, Watanabe F, Demetriou A. Artificial liver support systems. Biotechnol Bioeng 1996; 50: 382-91.
110. Hughes RD, Williams R. Assessment of bioartificial liver support in acute liver failure. Int J Artif Organs 1996; 19: 3-6.
111. Jauregui H, Mulion C, Trenkler D, et al. In vivo evaluation of a hollow fiber liver assist device. Hepatology 1995; 21: 460-9.
112. Nyberg S, Shirabe K, Peshwa M, et al. Extracorporeal application of a gel-entrapment, bioartificial liver: Demonstration of drug metabolism and other biochemical function. Cell Transplant 1993; 2: 441-52.
113. Ellis A, Hughes RD, Wendon J, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446-51.
114. Watanabe FD, Mullon CJP, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 1997; 225(5): 484-91.
115. Watanabe F, Shackleton CR, Cohen SM, et al. Treatment of acetaminophen-induced fulminant hepatic failure with a bioartiticial liver. Transplant Proc 1997; 29: 487-8.
116. Sussman N, Kully J. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 1993; 17: 27-30.
117. Sussman N, Finegold M, Barish J, Kelly J. A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device. Am J Gastroenterol 1994; 89: 1077-82.
118. Wang X, Andersson R. Hepatocyte transplantation: a potential treatment for acute liver failure. Scand J Gastroenterol 1995; 30: 195-200.
119. Bilir B, Durham JD, Krystal J, et al. Transjugular intra-portal transplantation of cryopreserved human hepatocytes in a patient with acute liver failure. Hepatology 1996; 24(4): Pt2 SS 728A.
120. Soriano HE, Wood RP, Kang DC, et al. Hepatocellular transplantation (HCT) in children with fulminant liver failure. Hepatology 1997; 26(4): Part 2 SS 239A.